0235-2990

Antibiot Khimioter = Antibiotics and Chemotherapy

Publishing House OKI

View prefix report (10.37489)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 98 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact98 DOIs
2

Add abstracts to 39 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact39 DOIs

DOIs for this ISSN

Showing the top 5 of 392 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Antiviral Activity of Kagocel<sup>®</sup> in vit… (10.37489/0235-2990-2020-65-3-4-3-6)
Abstract ORCID
45.15 7
2 The Effectiveness of Antifungal Agents Against Yeasts of Can… (10.37489/0235-2990-2020-65-3-4-16-22)
Abstract ORCID
34.95 4
3 Practical Experience of Using Riamilovir in Treatment of Pat… (10.37489/0235-2990-2020-65-7-8-27-30)
ORCID
31.97 18
4 The Corrective Effect of Fucoidan, a Sulfated Polysaccharide… (10.37489/0235-2990-2020-65-3-4-23-28)
Abstract ORCID
30.10 3
5 Methods and Approaches for Antibiotics Deteсtion (10.37489/0235-2990-2022-67-1-2-53-61)
ORCID
25.00 9
6 The Combined Effect of Bacteriophages and Antibiotics on Pse… (10.37489/0235-2990-2020-65-3-4-7-11)
Abstract ORCID
23.86 2
7 The Problem of Comorbid Socially Significant Infections Unde… (10.37489/0235-2990-2022-67-7-8-40-44)
Abstract ORCID
23.86 2
8 Etiological Characteristics in Causative Agents of Infectiou… (10.37489/0235-2990-2022-67-5-6-30-38)
Abstract
21.13 6
9 Study of the Wobenzym Enzyme Preparation Effect on the Forma… (10.37489/0235-2990-2024-69-1-2-10-14)
Abstract
21.13 6
10 Antiviral Activity of Kagocel® on the Model of Experimental… (10.37489/0235-2990-2020-65-1-2-15-20)
ORCID
19.45 5
11 Antibiotic-Resistant Uropathogenic <i>Escherichia coli… (10.37489/0235-2990-2020-65-7-8-23-26)
ORCID
19.45 5
12 Community-Acquired Pneumonia of Bacterial Etiology and the… (10.37489/0235-2990-2021-66-1-2-26-32)
ORCID
19.45 5
13 Comparative Effectiveness of Riamilovir and Umifenovir for T… (10.37489/0235-2990-2021-66-3-4-35-39)
ORCID
19.45 5
14 The Issue of Post-COVID Syndrome in Children and Adolescents… (10.37489/0235-2990-2022-67-11-12-51-55)
ORCID
19.45 5
15 Biapenem: Clinical and Microbiological Characteristics and t… (10.37489/0235-2990-2022-67-5-6-81-91)
Abstract
19.45 5
16 Evaluation of the Bactericidal Activity of Gramicidin S Agai… (10.37489/0235-2990-2022-67-7-8-8-18)
Abstract
19.45 5
17 Overview of the Risks of Antibiotic Contamination of Dairy P… (10.37489/0235-2990-2022-67-7-8-82-96)
Abstract
19.45 5
18 Toxicity of treatment regimens for drugresistant tuberculosi… (10.37489/0235-2990-2021-66-11-12-25-30)
ORCID
17.47 4
19 Mobile Genetic Elements of Prokaryotes and Their Role in the… (10.37489/0235-2990-2022-67-1-2-62-74)
ORCID
17.47 4
20 Molecular mechanisms of microbial resistance to disinfectant… (10.37489/0235-2990-2023-68-1-2-45-56)
ORCID
17.47 4
21 Antimicrobial Properties of Water-Soluble Polysaccharides an… (10.37489/0235-2990-2020-65-1-2-10-14)
ORCID
15.05 3
22 Determination of the Effectiveness of Antibiotic Therapy by… (10.37489/0235-2990-2020-65-3-4-29-33)
Abstract
15.05 3
23 The Modern State of Prevention and Treatment of Chikungunya… (10.37489/0235-2990-2020-65-3-4-45-53)
Abstract ORCID
15.05 1
24 Neurotoxic Side Effects of Antimicrobial and Anti-Tuberculos… (10.37489/0235-2990-2020-65-5-6-78-82)
ORCID
15.05 3
25 Probiotics and Autoprobiotics in the Treatment of Experiment… (10.37489/0235-2990-2022-67-11-12-29-35)
ORCID
15.05 3
26 The Effect of The Anolyte Solution on Pathogenic Microflora (10.37489/0235-2990-2022-67-5-6-10-13)
Abstract ORCID
15.05 1
27 Microbiomes of Kefir Grains From Regions of Historical Origi… (10.37489/0235-2990-2022-67-7-8-4-7)
Abstract ORCID
15.05 1
28 Rapid analysis of the effect of aminoglycosides on bacteria… (10.37489/0235-2990-2023-68-1-2-4-10)
ORCID
15.05 3
29 Evaluation of the Antiviral Activity of Drugs from the Group… (10.37489/0235-2990-2023-68-9-10-34-41)
ORCID
15.05 3
30 The Effect of Cefepime/Fluorothiazinone Compared with Cefepi… (10.37489/0235-2990-2024-69-9-10-31-39)
ORCID
15.05 3
31 Studying the Effectiveness of Ribavirin® in the Experimental… (10.37489/0235-2990-2020-65-1-2-21-26)
ORCID
11.93 2
32 The Influence of Polysaccharides from Sea Algae on the Patho… (10.37489/0235-2990-2020-65-1-2-44-53)
ORCID
11.93 2
33 Inhibiting Effect of Macrolide Polyene Antibiotics on Reprod… (10.37489/0235-2990-2020-65-1-2-54-60)
ORCID
11.93 2
34 The Development of a Turbidimetric Method for the Quantitati… (10.37489/0235-2990-2020-65-7-8-37-41)
ORCID
11.93 2
35 The Effectiveness of a Succinate-Containing Medication in Ac… (10.37489/0235-2990-2020-65-9-10-32-36)
ORCID
11.93 2
36 Analysis of Amoxicillin’s Antibacterial Activity Using Biol… (10.37489/0235-2990-2021-66-1-2-12-18)
ORCID
11.93 2
37 The Prospects of Succinates’ Use under Hypoxic Conditions in… (10.37489/0235-2990-2021-66-1-2-65-74)
ORCID
11.93 2
38 Anti-Mutant Efficacy of Combination Therapy with Doripenem a… (10.37489/0235-2990-2021-66-3-4-12-17)
ORCID
11.93 2
39 Approach to Searching for the Producers of Antibiotics That… (10.37489/0235-2990-2021-66-7-8-4-12)
ORCID
11.93 2
40 Enveloped Viruses: Pathogenetic Targets for Cyanobacterial L… (10.37489/0235-2990-2022-67-5-6-39-60)
Abstract
11.93 2
41 Study of the Antiviral Activity of Adamantane-Containing Che… (10.37489/0235-2990-2022-67-7-8-19-23)
Abstract
11.93 2
42 The Role of MHC Class I and Class II Molecules in Antibacter… (10.37489/0235-2990-2022-67-7-8-71-81)
Abstract
11.93 2
43 Study of Transitional Dynamics Towards the Non-Culturable St… (10.37489/0235-2990-2022-67-9-10-11-17)
ORCID
11.93 2
44 Study of Molecular Parameters and Antibacterial Activity of… (10.37489/0235-2990-2023-68-9-10-20-24)
ORCID
11.93 2
45 Microbial Sensor for Determination of Amoxicillin Activity (10.37489/0235-2990-2020-65-1-2-3-9)
ORCID
7.53 1
46 Regional Features of the Course of Pneumonia at the Present… (10.37489/0235-2990-2020-65-1-2-33-37)
ORCID
7.53 1
47 Vaccination in Rheumatology: New Data (Based on Recommendati… (10.37489/0235-2990-2020-65-1-2-61-67)
ORCID
7.53 1
48 Synergistic Effect of the Cationic Peptide Hominin and a New… (10.37489/0235-2990-2020-65-5-6-11-18)
ORCID
7.53 1
49 Analysis of the Microbial Landscape of Infection Site and th… (10.37489/0235-2990-2020-65-5-6-25-29)
ORCID
7.53 1
50 Immunogenicity, Tolerability, and Clinical Effectiveness of… (10.37489/0235-2990-2020-65-5-6-35-40)
ORCID
7.53 1